🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pancreatic Cancers

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain NCT07117032Phase 11 site📍 Cleveland Case Comprehensive Cancer Center · Tests: Simulation-free workflow, Celiac plexus SBRT The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation NCT06843551Phase 21 site📍 Miami Benjamin Spieler · Tests: Stereotactic Body Radiation Therapy, Botensilimab, Balstilimab Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers NCT02584244Phase 1, Phase 21 site📍 Boston Lumicell, Inc. · Tests: LUM015, LUM 2.6 Imaging Device Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations NCT06041009n/a1 site📍 Jinan Qilu Hospital of Shandong University · Tests: Pancreatic elastase-1 in blood serum Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy NCT04881487NA3 sites📍 Amsterdam📍 Rotterdam📍 Utrecht UMC Utrecht · Tests: Additional stereotactic body radiation therapy HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer NCT07131514Phase 21 site📍 Shanghai Ruijin Hospital · Tests: HRS-4642+AG +Adebrelimab A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies NCT04678648Phase 13 sites📍 Los Angeles📍 Denver📍 Nashville RasCal Therapeutics, Inc. · Tests: RSC-1255 Dose Escalation, RSC-1255 Dose Expansion Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer NCT07529626n/a3 sites📍 Changsha📍 Shanghai📍 Xi’an Shanghai Zhongshan Hospital An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site📍 Padova Azienda Ospedaliera di Padova A Study of JMT203 in Patients With Cancer Cachexia NCT06868849Phase 1, Phase 21 site📍 Zhejiang Shanghai JMT-Bio Inc. · Tests: JMT203 Injection, JMT203 Injection Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel NCT06483555Phase 1, Phase 21 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Gemcitabine, Nab paclitaxel, Erlotinib, NALIRIFOX, Folfirinox Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening NCT06549725NA16 sites📍 Prague📍 Brno📍 Brno Lipidica, a.s. · Tests: software Lipidica, endoscopic ultrasonography, magnetic resonance, laboratory examination, computed tomography The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer. NCT06601010n/a1 site📍 Shanghai Ruijin Hospital CtDNA-guided Maintenance Therapy in Pancreatic Cancer NCT07054879n/a1 site📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer NCT06953999Phase 33 sites📍 Harbin📍 Shanghai📍 Hangzhou Akeso · Tests: Ivonescimab, AK117, Albumin-bound Paclitaxel, Gemcitabine, Ivonescimab, AK117 Placebo, Albumin-bound Paclitaxel, Gemcit… Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites📍 Fairway📍 Bethesda National Cancer Institute (NCI) · Tests: Metarrestin Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC NCT07500259n/a1 site📍 Luxembourg Luxembourg Institute of Health · Tests: Personalized Functional Profiling A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762Phase 162 sites📍 Birmingham📍 Birmingham📍 Birmingham Seagen, a wholly owned subsidiary of Pfizer · Tests: PF-08046054, pembrolizumab Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients NCT05065801Phase 28 sites📍 Grenoble📍 Saint-Etienne📍 Reims Institut du Cancer de Montpellier - Val d'Aurelle · Tests: GEMBRAX/FOLFIRINOX Arm A, FOLFIRINOX Arm B ctDNA Assay in Patients With Resectable Pancreatic Cancer NCT05052671n/a2 sites📍 Oklahoma City📍 Tulsa University of Oklahoma Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers NCT06524973NA22 sites📍 Arcadia📍 Corona📍 Duarte City of Hope Medical Center · Tests: Telemedicine, Counseling, Best Practice, Questionnaire Administration, Inrweview Pancreatic Cancer Early Detection Consortium NCT04970056n/a60 sites📍 Phoenix📍 Scottsdale📍 Burbank Arbor Research Collaborative for Health 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors NCT07760012NA1 site📍 Beijing Peking University Third Hospital · Tests: 68Ga-SorB PET/CT CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Pharmacotyping of Pancreatic Patient-derived Organoids NCT05196334n/a1 site📍 Herlev Herlev Hospital · Tests: No intervention Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients NCT06730009Phase 1, Phase 21 site📍 Tainan Medigen Biotechnology Corporation · Tests: SLOG + Allogeneic NK cell, SLOG chemotherapy Lenvatinib Plus Chemotherapy for pNET Liver Metastases NCT07835893Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: Lenvatinib, Chemotherapy Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma NCT06861452Phase 1, Phase 21 site📍 Modena EIR Biotherapies s.r.l. · Tests: RR001 Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer NCT07408505NA1 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: Nano-crystalline megestrol acetate, First-line Chemotherapy Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA) NCT07262957Phase 41 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: HOP bundle
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy